Ireland· IE-PA-EU/1/18/1264/009-010
Alunbrig 180 mg film-coated tablets
A brigatinib product containing brigatinib, registered in Ireland by Takeda Pharma A/S.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Brigatinib
- Manufacturer
- Takeda Pharma A/S
- Country
- Ireland (IE)
- ATC code
- L01XE43
- ATC class
- Brigatinib
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/18/1264/009-010
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
576 interactions on record for brigatinib.
Graded by severity as the source publishes them — 126 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brigatinib · interactions on record
576 records
- 126 severe
- 442 moderate
- 8 minor
Most severe, free to view
- AprepitantA04AD12severe
- LonafarnibA16AX20severe
- VoxelotorB06AX03severe
- DronedaroneC01BD07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brigatinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayAlunbrigTakeda Pharma A/S (1)
- CzechiaALUNBRIGTakeda Pharma A/S, Vallensbaek Strand
- SpainALUNBRIG 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULATakeda Pharma A/S
- FinlandAlunbrigTakeda Pharma A/S
- FranceALUNBRIG 180 mg, comprimé pelliculéTAKEDA PHARMA (DANEMARK)
- IcelandAlunbrigTakeda Pharma A/S
- NetherlandsAlunbrig 180 mg, filmomhulde tabletAriad Pharma Ltd
- PolandAlunbrigTakeda Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Alunbrig
- Liechtenstein · Alunbrig
- Norway · Alunbrig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ceff180e-0ddb-49d3-a0f6-49cee1794798 GET /v1/drugs/ceff180e-0ddb-49d3-a0f6-49cee1794798?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01XE43"
],
"strength": null,
"pa_number": "EU/1/18/1264/009-010",
"substances": [
"Brigatinib"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "22/11/2018",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about brigatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.